Betazole

Betazole

SCHEMBL3336050

NCCc1ccn[nH]1.NCCc1ccn[nH]1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HRH2

The experimentally established mechanism targets of Betazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HRH2 known ✓ P25021 3/20 1.00
USP2 O75604 2/20 1.00
LMNA P02545 2/20 1.00
HRH1 P35367 6/20 0.40
HRH4 Q9H3N8 3/20 0.40
TSHR P16473 2/20 0.40
HRH3 Q9Y5N1 2/20 0.40
MIF P14174 1/20 0.40
LOXL2 Q9Y4K0 1/20 0.39
APEX1 P27695 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CHRNA7 P36544 1/20 0.34
AKT2 P31751 1/20 0.34
HTR1B P28222 1/20 0.33
KCNH2 Q12809 1/20 0.33
KDM4C Q9H3R0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Betazole SCHEMBL157156 1.00
Betazole SCHEMBL1237745 0.98
Betazole SCHEMBL1649674 0.98 HRH2 (0.95) HRH2USP2LMNAHRH1HRH4
Betazole SCHEMBL29633745 0.98 HRH2 (0.95) HRH2USP2LMNAHRH1HRH4
SCHEMBL4711257 0.86
Betazole SCHEMBL3336046 0.82 USP2 (0.68) HRH2USP2LMNAHRH1HRH4
SCHEMBL2183872 0.80
SCHEMBL4222977 0.76
SCHEMBL21721708 0.76
Bromide SCHEMBL10400923 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130059878-A1 TREATMENT OF DISEASES MODULATED BY A H4 RECEPTOR AGONIST LORIA EMILE (US) 2013-03-07 US disclosed
US-8207188-B2 Treatment of diseases modulated by a H4 receptor agonist NICOLAOU MICHALIS (US) 2012-06-26 US disclosed
US-20100144718-A1 TREATMENT OF DISEASES MODULATED BY A H4 RECEPTOR AGONIST NICOLAOU MICHALIS 2010-06-10 US disclosed